BNTX News and Press, BioNTech SE From 03/24/23

2023-03-24 11:07:24 ET BioNTech ( NASDAQ: BNTX ) is scheduled to announce Q4 earnings results on Monday, March 27th, before market open. The consensus EPS Estimate is $8.40 and the consensus Revenue Estimate is $4.19B Over the last 3 months, EPS estimates have seen 3 ...

2023-03-22 06:23:09 ET China's National Medical Products Administration (NMPA) approved CSPC Pharmaceutical's ( OTCPK:CSPCY ) ( OTCPK:CHJTF ) mRNA COVID vaccine SYS6006 for emergency use, marking the country's first domestically developed mRNA vaccine. CSPC said SYS6006...

2023-03-21 05:43:18 ET Moderna ( NASDAQ: MRNA ) plans to price its COVID-19 vaccine at ~$130 per dose in the U.S. going ahead, as vaccine purchases and distribution transitions to a commercial market from government-led procurements, Reuters reported citing Moderna's President S...

2023-03-20 11:54:54 ET BioNTech ( NASDAQ: BNTX ) announced an exclusive license and collaboration agreement with Rockville, Maryland-based biopharma OncoC4 on Monday to jointly develop and commercialize the latter’s experimental cancer candidate, ONC-392, for various soli...

BioNTech to receive exclusive worldwide license from OncoC4 to develop and commercialize its anti-CTLA-4 monoclonal antibody candidate, ONC-392 BioNTech and OncoC4 will co-develop ONC-392 as monotherapy or in combination with anti-PD1 in various solid tumor indications, with a randomized ...

2023-03-19 15:47:43 ET Although the COVID-19 pandemic ended up being a cash cow for several pharma and biotech companies, many of them are seeking other treatments to focus on to replace revenue that is beginning to fade away. With their mRNA vaccines, Moderna ( NASDAQ: MRNA ...

2023-03-16 01:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

MAINZ, Germany , March 13, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the full year and fourth quarter 2022 on Monday, March 27 th , 2023. BioNTech invites inv...

2023-03-06 11:35:57 ET Protection from the relatively new COVID-19 bivalent vaccines can wane as soon as two month after administration, according to a Finnish study. It also found that among chronically ill adults between the ages of 18 and 64, the bivalent vaccine did not reduce...

2023-03-06 09:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...